108 related articles for article (PubMed ID: 2274929)
1. Recombinant human erythropoietin increases blood pressure, platelet aggregability and platelet free calcium mobilisation in uraemic children: a possible link?
Van Geet C; Van Damme-Lombaerts R; Vanrusselt M; de Mol A; Proesmans W; Vermylen J
Thromb Haemost; 1990 Aug; 64(1):7-10. PubMed ID: 2274929
[TBL] [Abstract][Full Text] [Related]
2. Platelet intracellular calcium is not modified by subcutaneous administration of erythropoietin.
Lo Cascio C; Guzzo P; Loschiavo C; Manzato F; Lechi C
Thromb Haemost; 1994 Aug; 72(2):326-7. PubMed ID: 7831674
[No Abstract] [Full Text] [Related]
3. Modulation of platelet cytosolic calcium during erythropoietin therapy in uraemia.
Fluck RJ; Roger SD; McMahon AC; Raine AE
Nephrol Dial Transplant; 1994; 9(8):1109-14. PubMed ID: 7800209
[TBL] [Abstract][Full Text] [Related]
4. Novel erythropoiesis stimulating protein exerts an effect on platelet function in uremia equivalent to that exerted by recombinant human erythropoietin.
Fusté B; Escolar G; Cases A; López-Pedret J; Ordinas A; Díaz-Ricart M
Haematologica; 2002 May; 87(5):551-3. PubMed ID: 12010672
[No Abstract] [Full Text] [Related]
5. Treatment of uremic anemia with recombinant erythropoietin also reduces the defects in platelet adhesion and aggregation caused by uremic plasma.
Zwaginga JJ; IJsseldijk MJ; de Groot PG; Kooistra M; Vos J; van Es A; Koomans HA; Struyvenberg A; Sixma JJ
Thromb Haemost; 1991 Dec; 66(6):638-47. PubMed ID: 1665596
[TBL] [Abstract][Full Text] [Related]
6. Defective calcium signalling in uraemic platelets and its amelioration with long-term erythropoietin therapy.
Zhou XJ; Vaziri ND
Nephrol Dial Transplant; 2002 Jun; 17(6):992-7. PubMed ID: 12032187
[TBL] [Abstract][Full Text] [Related]
7. Blunted inhibition by insulin of agonist-stimulated calcium, pH and aggregatory responses in platelets from hypertensive patients.
Touyz RM; Schiffrin EL
J Hypertens; 1994 Nov; 12(11):1255-63. PubMed ID: 7868873
[TBL] [Abstract][Full Text] [Related]
8. Expression of fibrinogen receptors and GPIIb molecules on uraemic platelets: effect of recombinant human erythropoietin therapy.
Krzesłowska J; Rysz J; Cierniewski CS; Luciak M
Nephrol Dial Transplant; 1995; 10(5):653-6. PubMed ID: 7566578
[TBL] [Abstract][Full Text] [Related]
9. [Effect of human recombinant erythropoietin (rhuEPO) on platelet phospholipids in chronically hemodialysed].
Krawczyk W; Dmoszyńska A; Ledwozyw A; Soroka-Wojtaszko M
Acta Haematol Pol; 1993; 24(4):327-31. PubMed ID: 8303978
[TBL] [Abstract][Full Text] [Related]
10. The effect of erythropoietin on platelet function in uraemic children on haemodialysis.
Turi S; Soos J; Torday C; Bereczki C; Havass Z
Pediatr Nephrol; 1994 Dec; 8(6):727-32. PubMed ID: 7696114
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin improves signaling through tyrosine phosphorylation in platelets from uremic patients.
Diaz-Ricart M; Etebanell E; Cases A; López-Pedret J; Castillo R; Ordinas A; Escolar G
Thromb Haemost; 1999 Oct; 82(4):1312-7. PubMed ID: 10544920
[TBL] [Abstract][Full Text] [Related]
12. Haemostatic effects of recombinant human erythropoietin in chronic haemodialysis patients.
van Geet C; Hauglustaine D; Verresen L; Vanrusselt M; Vermylen J
Thromb Haemost; 1989 Feb; 61(1):117-21. PubMed ID: 2749585
[TBL] [Abstract][Full Text] [Related]
13. Platelet intracellular free calcium and hypertension.
Haller H; Lenz T; Thiede M; Lüdersdorf M; Kribben A; Distler A; Philipp T
J Clin Hypertens; 1987 Mar; 3(1):12-9. PubMed ID: 3572457
[TBL] [Abstract][Full Text] [Related]
14. Human erythropoietin improves the blood platelet phospholipid composition in chronically hemodialyzed patients.
Krawczyk W; Dmoszyńska A; Marczewski K; Ledwozyw A
Exp Nephrol; 1995; 3(4):265-6. PubMed ID: 8590040
[TBL] [Abstract][Full Text] [Related]
15. Effects of quercetin on aggregation and intracellular free calcium of platelets.
Xiao D; Gu ZL; Bai JP; Wang Z
Zhongguo Yao Li Xue Bao; 1995 May; 16(3):223-6. PubMed ID: 7660815
[TBL] [Abstract][Full Text] [Related]
16. Free intracellular calcium in essential hypertension. Effects of nifedipine and captopril.
Lenz T; Haller H; Lüdersdorf M; Kribben A; Thiede M; Distler A; Philipp T
J Hypertens Suppl; 1985 Dec; 3(3):S13-5. PubMed ID: 2856689
[TBL] [Abstract][Full Text] [Related]
17. Effect of exogenous mineralocorticoid on platelet cytosolic calcium in normal humans.
Haller H; Bock A; Harwig S; Distler A; Luft FC
J Hum Hypertens; 1995 Apr; 9(4):249-54. PubMed ID: 7595907
[TBL] [Abstract][Full Text] [Related]
18. Enhanced platelet reactivity with erythropoietin but not following transfusion in dialysis patients.
Roger SD; Piper J; Tucker B; Raine AE; Baker LR; Kovacs IB
Nephrol Dial Transplant; 1993; 8(3):213-7. PubMed ID: 8385286
[TBL] [Abstract][Full Text] [Related]
19. Effect of recombinant human erythropoietin treatment on circulating reticulated platelets in uremic patients: association with early improvement in platelet function.
Tàssies D; Reverter JC; Cases A; Calls J; Escolar G; Ordinas A
Am J Hematol; 1998 Oct; 59(2):105-9. PubMed ID: 9766793
[TBL] [Abstract][Full Text] [Related]
20. N-Ethylmaleimide induces disaggregation of platelets preaggregated by ADP and thrombin and decreases cytoplasmic calcium level.
Samal AB; Loiko EN
Biochemistry (Mosc); 2000 Feb; 65(2):230-6. PubMed ID: 10713553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
